Bacterial Antigens Market 2028 By Product, Pathogen Type, Application, End user and Geography | The Insight Partners

report image

Bacterial Antigens Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Chlamydia trachomatis, Native Chlamydia trachomatis, Clostridium difficile Toxoid A, Clostridium difficile Toxoid B, Native Lipoteichoic Acid, Neisseria gonorrhoeae, Recombinant Protein G, Trichomonas vaginalis); Pathogen Type (Inactivated Pathogen, Purified Pathogen); Application (ELISA, Immunoassay, SDS-PAGE, Hemagglutination, Agglutination test); End user (Hospital and Clinics, Diagnostic Laboratories and Centers, Academic and Research Institutes) and Geography

Report Code: TIPRE00024415 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET OVERVIEW

Antigens are chemical substances that are capable of triggering an immune response in the host body by initiating antibodies production that helps resist bacterial infections. Depending upon the antigen source, i.e., whether they enter the body from outside or originate within the body, the antigens can be classified into self-antigens and foreign antigens. The foreign antigens include viruses, parasites, bacteria, and many more. The bacterial antigen antigenic determinant portion is recognized by antigen-specific receptors present on T and B cells. These determinants induce a strong immune response and, therefore, are used to generate antibodies for research purposes.

MARKET SCOPE

The "Global Bacterial Antigens Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the bacterial antigens market with detailed market segmentation by product, pathogen type, application, end user, and geography. The report provides key statistics on the market status of the leading bacterial antigens market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on product, the global bacterial antigens market is segmented into Chlamydia trachomatis, Native Chlamydia trachomatis, Clostridium difficile Toxoid A, Clostridium difficile Toxoid B, Native Lipoteichoic Acid, Neisseria gonorrhoeae, Recombinant Protein G and Trichomonas vaginalis.
  •  On the basis of pathogen type, the market is bifurcated into inactivated pathogen and purified pathogen.
  •  Based on application, the market is segmented into ELISA, immunoassay, SDS-PAGE, hemagglutination and agglutination test.
  •  On the basis of end-users, the market is bifurcated into hospital and clinics, diagnostic laboratories and centers, academic and research institutes.

MARKET DYNAMICS

Drivers:

  •  Increase in the demand for bacterial antigens capable of eliciting a protective immune response against infectious diseases.
  •  Rise in incidences of cancer and infectious diseases.
  •  Product approval and launch of new bacterial antigens.
  •  Growing number of diagnostic tests performed in humans.

Restraints:

  •  Rise in the risk of bacterial infection in the host.
  •  Stringent government policies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The bacterial antigens market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the bacterial antigens market in these regions.

IMPACT OF COVID-19ON BACTERIAL ANTIGENS MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic outbreak influenced the bacterial antigens market growth due to worldwide lockdown. All the focus was shifted towards COVID-19 patients, which affected the market growth. Moreover, business shutdowns, supply, and trade disruptions further had a negative impact on the market. However, the upliftment of imposed restrictive measures and increased research activities related to bacterial antigens will help the market witness growth in the forecast period.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the bacterial antigens market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from bacterial antigens market are anticipated to have lucrative growth opportunities in the future with the rising demand for bacterial antigens in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the bacterial antigens market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Bio-Rad Laboratories, Inc.
  •  Enzo Life Sciences, Inc.
  •  Creative Diagnostics
  •  The Native Antigen Company Ltd.
  •  QED Bioscience Inc.
  •  Microbix Biosystems
  •  Ross Southern Laboratories
  •  Jena Bioscience GmbH
  •  SERION Immunologics
  •  AROTEC Diagnostics
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

The List of Companies

1. Bio-Rad Laboratories, Inc.
2. Enzo Life Sciences, Inc.
3. Creative Diagnostics
4. The Native Antigen Company Ltd.
5. QED Bioscience Inc.
6. Microbix Biosystems
7. Ross Southern Laboratories
8. Jena Bioscience GmbH
9. SERION Immunologics
10. AROTEC Diagnostics
TIPRE00024415
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




tip-analyst

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount